Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemotherapy in Intraocular Retinoblastoma
NCT00002675Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 1995
- Primary completion
- Jan 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of carboplatin in retinoblastoma (Rb), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Response Rate to Adjuvant Carboplatin. Started May 1995; status: completed.
02
Drugs
carboplatin
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on NCT00002675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002675.